US71715X2036 - PMCB (XNAS)
PharmaCyte Biotech, Inc. - Common Stock Aktie
1,90 USD
Aktuelle Kurse von PharmaCyte Biotech, Inc. - Common Stock
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
PMCB
|
USD
|
20.09.2024 21:10
|
1,90 USD
| 2,01 USD | -5,47 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
-5,47 % | 0,00 % | 1,60 % | -9,09 % | -11,21 % | -23,69 % | -96,69 % |
Firmenprofil zu PharmaCyte Biotech, Inc. - Common Stock Aktie
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for pancreatic and other solid cancerous tumors; a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes, which include encapsulated genetically modified insulin-producing cells; and therapies for cancer based on the constituents of the cannabis plant. It has a research agreement with the University of Technology, Sydney to create a version of melligen cells to treat diabetes; and the University of Northern Colorado to develop methods for the identification, separation, and quantification of constituents of cannabis. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
Unternehmensdaten zur PharmaCyte Biotech, Inc. - Common Stock Aktie
Name PharmaCyte Biotech, Inc. - Common Stock
Firma PharmaCyte Biotech, Inc.
Symbol PMCB
Website https://pharmacyte.com
Heimatbörse
NASDAQ
ISIN US71715X2036
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Joshua N. Silverman
Marktkapitalisierung 12 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
Adresse 3960 Howard Hughes Parkway, 89169 Las Vegas
IPO Datum 2013-01-02
Aktien Kennungs-Wechsel
Datum | Von | Zu |
---|---|---|
09.01.2015 | NVLX | PMCB |
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | PMCB |
Weitere Aktien
Investoren die PharmaCyte Biotech, Inc. - Common Stock halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024